A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds. . . . → Read More: Animal Genome Biotech Raises $9M in Seed Funds
|
|||||
       
  |
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray 
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial 
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies 
A new poll shows a jump in the percentage of American workers now required by employers to get vaccinated against Covid-19. . . . → Read More: Infographic – US Employer Vaccine Mandates Tick Up 
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies 
The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms. . . . → Read More: FDA Sends Warning on Covid-19 Food Therapy Trials 
The global Covid-19 pandemic requires a global response, but so far delivery and administration of vaccines are spread unevenly across the world. . . . → Read More: Infographic – Most of World Waits for Vaccines  Comments are closed  New products  biomedical, Covid-19, economics, health care, pharmaceuticals, statistics 
A company designing synthetic viruses that attack antibiotic-resistant bacteria is receiving National Science Foundation funds to advance its work. . . . → Read More: Small Biz Grant Funds Superbug Therapy Technology Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, genomics, grant, life sciences, mathematics, NSF, pharmaceuticals, physical sciences 
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $108M in New Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
